High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
Fallet, V., Saffroy, R., Girard, N., Mazieres, J., Lantuejoul, S., Vieira, T., Rouquette, I., Thivolet-Bejui, F., Ung, M., Poulot, V., Schlick, L., Moro-Sibilot, D., Antoine, M., Cadranel, J., Lemoine, A., Wislez, M.
Published in Annals of oncology (01.08.2015)
Published in Annals of oncology (01.08.2015)
Get full text
Journal Article
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy
Giroux Leprieur, E, Antoine, M, Vieira, T, Duruisseaux, M, Poulot, V, Rabbe, N, Belmont, L, Gounant, V, Lavolé, A, Milleron, B, Lacave, R, Cadranel, J, Wislez, M
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2013)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2013)
Get full text
Journal Article
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
BORGET, I, CADRANEL, J, DANIEL, C, MORIN, F, CHOUAID, C, PIGNON, J.-P, QUOIX, E, COUDERT, B, WESTEEL, V, DANSIN, E, MADELAINE, J, MADROSZYK, A, FRIARD, S
Published in The European respiratory journal (01.01.2012)
Published in The European respiratory journal (01.01.2012)
Get full text
Journal Article
IFCT0401-bio phase II trial: Gefitinib administered as 1st-line in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC)—Predictive biomarkers of efficacy and survival
Wislez, m., Antoine, M., Poulot, V., Baudrin, L., Beau-Faller, M., Morere, J., Brambilla, E., Lebitasy, M., Coulet, F., Cadranel, J.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A simple view on lung cancer biology: The EGFR pathway
Ruppert, A-M, Wislez, M, Poulot, V, Lacave, R, Antoine, M, Cadranel, J
Published in Revue des maladies respiratoires (01.04.2011)
Published in Revue des maladies respiratoires (01.04.2011)
Get more information
Journal Article
IFCT0401-bio trial: Predictive biological markers for disease control (DC) of patients with non-resectable, adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC) treated with gefitinib
Wislez, M., Antoine, M., Poulot, V., Morere, J. F., Perol, M., Souquet, P. J., Lebitasy, M. P., Zalcman, G., Coulet, F., Cadranel, J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
IFCT0401-bio trial: Pathological and EGF-r molecular analysis of tumor-biopsy samples from patients with non-resectable, pneumonic-type adenocarcinoma (P-ADC) treated by gefinitib. Preliminary results from surgical specimens
Cadranel, J., Wislez, M., Coulet, F., Poulot, V., Morã, J. F., Debove, P., Perol, M., Souquet, P. J., Soubrier, F., Antoine, M.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article